- Report
- May 2025
- 76 Pages
Africa, Middle East
From €2607EUR$2,950USD£2,297GBP
- Report
- September 2024
- 593 Pages
Global
From €4241EUR$4,799USD£3,736GBP
- Report
- November 2024
- 343 Pages
Global
From €4241EUR$4,799USD£3,736GBP
- Report
- January 2020
- 473 Pages
Global
From €4329EUR$4,899USD£3,814GBP
- Report
- October 2018
- 450 Pages
Global
From €3092EUR$3,499USD£2,724GBP
- Report
- March 2024
- 329 Pages
Global
From €5110EUR$5,986USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5110EUR$5,986USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5110EUR$5,986USD£4,350GBP
- Report
- July 2024
- 154 Pages
Global
From €3402EUR$3,850USD£2,997GBP
- Report
- September 2023
- 234 Pages
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- November 2024
- 185 Pages
Global
From €3402EUR$3,850USD£2,997GBP
- Report
- January 2024
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- December 2023
- 217 Pages
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- June 2023
- 200 Pages
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- June 2023
- 235 Pages
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- April 2022
- 250 Pages
Global
From €6053EUR$6,850USD£5,333GBP
- Report
- January 2022
- 100 Pages
Global
€3402EUR$3,850USD£2,997GBP
- Report
- December 2021
- 170 Pages
Global
€3402EUR$3,850USD£2,997GBP
- Report
- September 2021
- 100 Pages
Global
€3402EUR$3,850USD£2,997GBP
- Report
- September 2024
- 719 Pages
Global
From €4374EUR$4,950USD£3,854GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more